NATCO PHARMA (India) Today

NATCOPHARM -  India Stock  

INR 872.45  9.60  1.09%

NATCO PHARMA is trading at 872.45 as of the 21st of October 2021. This is a -1.09 percent decrease since the beginning of the trading day. The stock's open price was 882.05. NATCO PHARMA has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for NATCO PHARMA LTD are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 21st of September 2021 and ending today, the 21st of October 2021. Click here to learn more.
 Market Performance
0 of 100
  Odds Of Distress
Less than 2
NATCO Pharma Limited, a pharmaceutical company, develops, manufactures, and markets finished dosage formulations and active pharmaceutical ingredients . The company markets its products in approximately 40 countries, including India, the United States, and internationally.NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India. The company has 182.34 M outstanding shares. More on NATCO PHARMA LTD
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

NATCO PHARMA Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. NATCO PHARMA's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding NATCO PHARMA or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
NATCO PHARMA LTD generated a negative expected return over the last 90 days
NATCO PHARMA LTD is unlikely to experience financial distress in the next 2 years
About 51.0% of the company outstanding shares are owned by corporate insiders
Legal NameNATCO PHARMA LTD
ChairmanRajeev Nannapaneni  (View All)
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of NATCO PHARMA's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
NATCO PHARMA LTD (NATCOPHARM) is traded on National Stock Exchange of India in India and employs 5,026 people. The company currently falls under 'Mega-Cap' category with current market capitalization of 164.32 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate NATCO PHARMA's market, we take the total number of its shares issued and multiply it by NATCO PHARMA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. NATCO PHARMA LTD operates under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 182.34 M outstanding shares. NATCO PHARMA LTD has accumulated about 8.55 B in cash with 2.99 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 46.93.
Check NATCO PHARMA Probability Of Bankruptcy
Ownership
NATCO PHARMA LTD maintains a total of one hundred eighty-two million three hundred fourty thousand outstanding shares. NATCO PHARMA LTD holds noticeable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how much assets the company has, if the real value of the entity is less than the current market value, you may not be able to make money on it.

Ownership Allocation (%)

Check NATCO Ownership Details

NATCO Stock Price Odds Analysis

What are NATCO PHARMA's target price odds to finish over the current price? In reference to a normal probability distribution, the odds of NATCO PHARMA jumping above the current price in 90 days from now is about 92.11%. The NATCO PHARMA LTD probability density function shows the probability of NATCO PHARMA stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon NATCO PHARMA has a beta of 0.357. This indicates as returns on the market go up, NATCO PHARMA average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding NATCO PHARMA LTD will be expected to be much smaller as well. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. NATCO PHARMA LTD is significantly underperforming DOW.
 Odds Down 872.45HorizonTargetOdds Up 872.45 
7.82%90 days
 872.45 
92.11%
Based on a normal probability distribution, the odds of NATCO PHARMA to move above the current price in 90 days from now is about 92.11 (This NATCO PHARMA LTD probability density function shows the probability of NATCO Stock to fall within a particular range of prices over 90 days) .

NATCO PHARMA LTD Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. NATCO PHARMA market risk premium is the additional return an investor will receive from holding NATCO PHARMA long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in NATCO PHARMA. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although NATCO PHARMA's alpha and beta are two of the key measurements used to evaluate NATCO PHARMA's performance over the market, the standard measures of volatility play an important role as well.

NATCO Stock Against Markets

Picking the right benchmark for NATCO PHARMA stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in NATCO PHARMA stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for NATCO PHARMA is critical whether you are bullish or bearish towards NATCO PHARMA LTD at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in NATCO PHARMA without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Diagnostics Now

   

Portfolio Diagnostics

Use generated alerts and portfolio events aggregator to diagnose current holdings
All  Next Launch Module

NATCO PHARMA Corporate Executives

Elected by the shareholders, the NATCO PHARMA's board of directors comprises two types of representatives: NATCO PHARMA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of NATCO. The board's role is to monitor NATCO PHARMA's management team and ensure that shareholders' interests are well served. NATCO PHARMA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, NATCO PHARMA's outside directors are responsible for providing unbiased perspectives on the board's policies.
S Rao - Interim CFO and VP of Fin. and AccountsProfile
Additionally, see Stocks Correlation. Note that the NATCO PHARMA LTD information on this page should be used as a complementary analysis to other NATCO PHARMA's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Global Correlations module to find global opportunities by holding instruments from different markets.

Other Tools for NATCO Stock

When running NATCO PHARMA LTD price analysis, check to measure NATCO PHARMA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NATCO PHARMA is operating at the current time. Most of NATCO PHARMA's value examination focuses on studying past and present price action to predict the probability of NATCO PHARMA's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move NATCO PHARMA's price. Additionally, you may evaluate how the addition of NATCO PHARMA to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go